(Q42983405)

English

Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.

scientific article published on 21 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Martina Friesland

3

object named as

Martina Friesland

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Ute Gravemann

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Juliane Doerrbecker

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Thomas Pietschmann

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Axel Seltsam

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 August 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1010-1018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Evolving epidemiology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Hepatitis C: the clinical spectrum of disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Treating viral hepatitis C: efficacy, side effects, and complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

A new era of hepatitis C therapy begins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Transmission of hepatitis C virus by a cardiac surgeon.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Viral hepatitis transmission in ambulatory health care settings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Transfusion-transmissible viral infections among US military recipients of whole blood and platelets during Operation Enduring Freedom and Operation Iraqi Freedom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Robust hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Updates on pathogen inactivation of plasma using Theraflex methylene blue system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Dynamics of viremia in early hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Virus inactivation in blood components by photoactive phenothiazine dyes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Target structures for HIV-1 inactivation by methylene blue and light.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Photodynamic virus inactivation of blood components

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

West Nile virus in plasma is highly sensitive to methylene blue-light treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Ultraviolet radiation-mediated damage to cellular DNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

UV-induced DNA damage and repair: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Predicted inactivation of viruses of relevance to biodefense by solar radiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Inactivation and survival of hepatitis C virus on inanimate surfaces

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Turning hepatitis C into a real virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03858.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2012.03858.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22905868%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42983405&oldid=1636564582"